Uterine Cervical Neoplasms
"Uterine Cervical Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UTERINE CERVIX.
| Descriptor ID |
D002583
|
| MeSH Number(s) |
C04.588.945.418.948.850 C13.351.500.852.593.131 C13.351.500.852.762.850 C13.351.937.418.875.850
|
| Concept/Terms |
Uterine Cervical Neoplasms- Uterine Cervical Neoplasms
- Cervical Neoplasm, Uterine
- Cervical Neoplasms, Uterine
- Neoplasm, Uterine Cervical
- Neoplasms, Uterine Cervical
- Uterine Cervical Neoplasm
- Neoplasms, Cervical
- Cervical Neoplasms
- Cervical Neoplasm
- Neoplasm, Cervical
- Neoplasms, Cervix
- Cervix Neoplasms
- Cervix Neoplasm
- Neoplasm, Cervix
Cancer of the Uterine Cervix- Cancer of the Uterine Cervix
- Cancer of the Cervix
- Cervical Cancer
- Uterine Cervical Cancer
- Cancer, Uterine Cervical
- Cancers, Uterine Cervical
- Cervical Cancer, Uterine
- Cervical Cancers, Uterine
- Uterine Cervical Cancers
- Cancer of Cervix
- Cervix Cancer
- Cancer, Cervix
- Cancers, Cervix
|
Below are MeSH descriptors whose meaning is more general than "Uterine Cervical Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uterine Cervical Neoplasms".
This graph shows the total number of publications written about "Uterine Cervical Neoplasms" by people in this website by year, and whether "Uterine Cervical Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 1 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 4 | 0 | 4 |
| 2003 | 4 | 0 | 4 |
| 2004 | 6 | 0 | 6 |
| 2005 | 5 | 1 | 6 |
| 2006 | 7 | 1 | 8 |
| 2007 | 6 | 1 | 7 |
| 2008 | 6 | 3 | 9 |
| 2009 | 11 | 1 | 12 |
| 2011 | 3 | 0 | 3 |
| 2012 | 8 | 0 | 8 |
| 2013 | 5 | 1 | 6 |
| 2014 | 6 | 1 | 7 |
| 2015 | 7 | 1 | 8 |
| 2016 | 8 | 0 | 8 |
| 2017 | 10 | 0 | 10 |
| 2018 | 11 | 0 | 11 |
| 2019 | 13 | 2 | 15 |
| 2020 | 18 | 1 | 19 |
| 2021 | 6 | 0 | 6 |
| 2022 | 8 | 0 | 8 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
| 2025 | 7 | 1 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uterine Cervical Neoplasms" by people in Profiles.
-
Association Between Regional Competition and Cancer Screening Rates at Federally Qualified Health Centers. J Ambul Care Manage. 2026 Jan-Mar 01; 49(1):E40-E48.
-
Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263). Gynecol Oncol. 2025 Nov; 202:102-109.
-
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical Hysterectomy. JAMA Netw Open. 2025 May 01; 8(5):e2510717.
-
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial. Gynecol Oncol. 2025 Apr; 195:122-133.
-
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278). Gynecol Oncol. 2025 Apr; 195:50-58.
-
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278). Gynecol Oncol. 2025 Apr; 195:59-65.
-
Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 2025 Feb 15; 131(4):e35757.
-
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.
-
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892). Cancer Chemother Pharmacol. 2024 Dec 14; 95(1):4.
-
Targeting HSP70-E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical Cancer. J Med Virol. 2024 Nov; 96(11):e70088.